My biggest concern last fall was, "what if Bernie gets into office?" This fear was driven partially by the fact that the market would likely sell off with the democratic socialist in charge, but more so by the concern...
In this, our third article about Fortress Biotech (FBIO), we discuss the value of two in-house subsidiaries, Journey Medical and Caelum BioSciences. Both entities have unique aspects which add considerably to the value of the parent company. Our prior two...
My Take on The Market This was a good week in the market, which was a welcome relief. We had a big bailout announced by the federal government and some estimates of how bad COVID19 could be came down a...
Normally I love my Saturday mornings. This is when I write the weekly newsletter and it gives me a chance to review the prior week in the market and look for meaningful insight into our companies and what investors...
Tailwinds' Take: 2019 was a very impressive year of accomplishment for FBIO. The stage is set for a big 2020 as well, with many catalysts coming. The balance sheet and earnings can be confusing due to consolidation of subsidiaries,...
Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that I couldn't have agreed more. Stocks are in free-fall, the country is entering a national...
Tailwinds' Take: with a pivotal trial ongoing, CKPT is another hidden gem in FBIO's vault. Funded through YE 2021 with hopes for BLA submission on Cosibelmab prior to then. NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc....
As I look out my office window here in NorCal and see the blossoms on the tree, it's tough to remember that it's still winter for most of the country. The drought seems to have returned here which means...
Fortress Biotech (FBIO) has an interesting business model that involves an operating subsidiary focused on dermatology and multiple other partially owned subsidiaries that are independently managed and financed yet consolidated under their umbrella. Our first article on Fortress discussed...
Tailwinds' Take: very exciting news for FBIO's 1/3 owned subsidiary, Mustang Bio. Expect to see the street taking targets up for MBIO, which is just another reason to own Fortress. NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Mustang Bio,...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.